Home > News > New Clinical Trial with MagForce® Nano-Cancer Therapy
January 13th, 2006
New Clinical Trial with MagForce® Nano-Cancer Therapy
Abstract:
In January 2006 another clinical study was started on the MagForce® Nano-Cancer Therapy, this time enrolling patients suffering from metastasized esophageal cancer. This study is being performed at the Klinik für Chirurgie und Chirurgische Onkologie, Charité Berlin (Director: Prof. Dr. med. Peter M. Schlag) under the leadership of PD Dr. med. Beate Rau together with Dr. med. S. Koswig and Dr. med. P. Reichard. (PDF)
Source:
mag-force.de
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||